Galapagos Loses Potential Ticket To America As Crohns Trial Flops

 
• By Alaric DeArment
  
Galapagos said its Phase III trial of Jyseleca failed in induction treatment of Crohn's disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D